Your Good Partner in Biology Research

重組蛋白

產(chǎn)品名稱 貨號(hào) 規(guī)格
Recombinant Campylobacter hominis Cysteine--tRNA ligase (cysS) CSB-YP418994CWD
CSB-EP418994CWD
CSB-BP418994CWD
CSB-MP418994CWD
CSB-EP418994CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis tRNA modification GTPase MnmE (mnmE) CSB-YP418995CWD
CSB-EP418995CWD
CSB-BP418995CWD
CSB-MP418995CWD
CSB-EP418995CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Phosphoglycerate kinase (pgk) CSB-YP418996CWD
CSB-EP418996CWD
CSB-BP418996CWD
CSB-MP418996CWD
CSB-EP418996CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Putative nickel-responsive regulator (CHAB381_0870) CSB-YP418997CWD
CSB-EP418997CWD
CSB-BP418997CWD
CSB-MP418997CWD
CSB-EP418997CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 30S ribosomal protein S15 (rpsO) CSB-YP418998CWD
CSB-EP418998CWD
CSB-BP418998CWD
CSB-MP418998CWD
CSB-EP418998CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Protein CrcB homolog (crcB), partial CSB-YP418999CWD1
CSB-EP418999CWD1
CSB-BP418999CWD1
CSB-MP418999CWD1
CSB-EP418999CWD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis UDP-N-acetylglucosamine--N-acetylmuramyl- (pentapeptide) pyrophosphoryl-undecaprenol N-acetylglucosamine transferase CSB-YP419000CWD
CSB-EP419000CWD
CSB-BP419000CWD
CSB-MP419000CWD
CSB-EP419000CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis SsrA-binding protein (smpB) CSB-YP419001CWD
CSB-EP419001CWD
CSB-BP419001CWD
CSB-MP419001CWD
CSB-EP419001CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Histidinol-phosphate aminotransferase (hisC) CSB-YP419002CWD
CSB-EP419002CWD
CSB-BP419002CWD
CSB-MP419002CWD
CSB-EP419002CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Ribonuclease Y (rny), partial CSB-YP419003CWD
CSB-EP419003CWD
CSB-BP419003CWD
CSB-MP419003CWD
CSB-EP419003CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Large-conductance mechanosensitive channel (mscL), partial CSB-YP419004CWD1
CSB-EP419004CWD1
CSB-BP419004CWD1
CSB-MP419004CWD1
CSB-EP419004CWD1-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Phosphate acyltransferase (plsX) CSB-YP419005CWD
CSB-EP419005CWD
CSB-BP419005CWD
CSB-MP419005CWD
CSB-EP419005CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Lysine--tRNA ligase (lysS) CSB-YP419006CWD
CSB-EP419006CWD
CSB-BP419006CWD
CSB-MP419006CWD
CSB-EP419006CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 30S ribosomal protein S7 (rpsG) CSB-YP419007CWD
CSB-EP419007CWD
CSB-BP419007CWD
CSB-MP419007CWD
CSB-EP419007CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis 50S ribosomal protein L33 (rpmG) CSB-YP419008CWD
CSB-EP419008CWD
CSB-BP419008CWD
CSB-MP419008CWD
CSB-EP419008CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis UPF0763 protein CHAB381_1696 (CHAB381_1696) CSB-YP419009CWD
CSB-EP419009CWD
CSB-BP419009CWD
CSB-MP419009CWD
CSB-EP419009CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Ribosomal RNA small subunit methyltransferase A (rsmA) CSB-YP419010CWD
CSB-EP419010CWD
CSB-BP419010CWD
CSB-MP419010CWD
CSB-EP419010CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Campylobacter hominis Crossover junction endodeoxyribonuclease RuvC (ruvC) CSB-YP419011CWD
CSB-EP419011CWD
CSB-BP419011CWD
CSB-MP419011CWD
CSB-EP419011CWD-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanoregula boonei Holliday junction ATP-dependent DNA helicase RuvB (ruvB) CSB-YP419012MNV
CSB-EP419012MNV
CSB-BP419012MNV
CSB-MP419012MNV
CSB-EP419012MNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)
Recombinant Methanoregula boonei 50S ribosomal protein L40e (rpl40e) CSB-YP419013MNV
CSB-EP419013MNV
CSB-BP419013MNV
CSB-MP419013MNV
CSB-EP419013MNV-B
20μg/100μg/1mg(1mg*1 or 500ug*2)

有用資源

什么是重組蛋白?

重組蛋白是一種可操縱的蛋白質(zhì)形式,可以通過(guò)多種方式產(chǎn)生大量蛋白質(zhì)、修改基因序列和制造有用的商業(yè)產(chǎn)品。重組蛋白的技術(shù)資源在重組蛋白的開發(fā)過(guò)程中,除了表達(dá)系統(tǒng)之外,還面臨著一系列令人困惑的選擇,如表達(dá)載體的選擇、表達(dá)蛋白的長(zhǎng)度(全長(zhǎng)或部分)、是否帶標(biāo)簽等。在生產(chǎn)重組蛋白時(shí),你必須做出很多決定。如果你選擇的明智,你將獲得高質(zhì)量的重組蛋白,后續(xù)的實(shí)驗(yàn)更有可能成功。但是如果你做了錯(cuò)誤的決定,你可能得不到你所需要的重組蛋白或者重組蛋白的質(zhì)量和純度不符合要求。在這里,來(lái)自CUSABIO的蛋白表達(dá)工程師根據(jù)他們開發(fā)重組蛋白的經(jīng)驗(yàn)總結(jié)出了幾個(gè)有用的提示,可以幫助你做出明智的決策。

第一條:重組蛋白的生產(chǎn),在這篇文章中,我們旨在闡明重組蛋白的定義以及如何生產(chǎn)重組蛋白。

第二條:如何選擇合適的表達(dá)載體?

表達(dá)載體是一種DNA分子,它攜帶特定的基因進(jìn)入宿主細(xì)胞,并利用細(xì)胞的蛋白質(zhì)合成機(jī)制來(lái)產(chǎn)生由該基因編碼的蛋白質(zhì)。表達(dá)載體可使外源基因在宿主細(xì)胞中高效表達(dá),經(jīng)過(guò)多年的發(fā)展,表達(dá)載體已成為一種成熟而受歡迎的生物技術(shù)。在重組蛋白生產(chǎn)過(guò)程中是一種基本成分。正如標(biāo)題所示,本文主要總結(jié)了幾個(gè)有用的技巧來(lái)選擇合適的表達(dá)載體。

第三條:如何表達(dá)具有生物活性的蛋白質(zhì)?

根據(jù)重組蛋白的不同應(yīng)用,對(duì)其生物活性有不同的要求。但是我們?nèi)绾未_保蛋白質(zhì)的產(chǎn)生具有生物活性呢?本文將圍繞這個(gè)主題,并提供一些解決方案。除了以上文章,我們還收集了一些重組蛋白的常見(jiàn)問(wèn)題。您可以單擊以下鏈接查看。http://m.cstxtech.com/technology-91.html。此外,我們還為我們的客戶提供重組蛋白表達(dá)服務(wù),您可以點(diǎn)擊這里獲取更多信息。注:如果您對(duì)CUSABIO的蛋白質(zhì)有任何疑問(wèn),涉及到蛋白質(zhì)的價(jià)格、交貨、質(zhì)量等,您可以點(diǎn)擊橙色按鈕為我們?cè)诰€留言。

引用資料

Recombinant Severe acute respiratory syndrome coronavirus 2 RNA-dependent RNA polymerase(NSP12) cited in "SARS-CoV-2 hijacks cellular kinase CDK2 to promote viral RNA synthesis". Signal transduction and targeted therapy, 2023

Recombinant Mouse Mixed lineage kinase domain-like protein(Mlkl) cited in "OASL phase condensation induces amyloid-like fibrillation of RIPK3 to promote virus-induced necroptosis". Nature cell biology, 2023

Recombinant Mouse Proto-oncogene c-Fos(Fos) cited in "Dihydroartemisinin imposes positive and negative regulation on Treg and plasma cells via direct interaction and activation of c-Fos". Communications biology, 2023

Recombinant Human Keratin, type I cytoskeletal 18(KRT18) cited in "Calcitonin gene-related peptide ameliorates sepsis-induced intestinal injury by suppressing NLRP3 inflammasome activation". International immunopharmacology, 2023

Recombinant Human Protein Wnt-5a (WNT5A) cited in "ATBF1 is a potential diagnostic marker of histological grade and functions via WNT5A in breast cancer". BMC Cancer, 2022

Read More >>